Back to the main directory
EarningsReview / Equity
- CMD Feedback by BNP Paribas Exane
- Blip, recovery, turbocharged growth by BNP Paribas Exane
- How to beat the cistern by BNP Paribas Exane
- Prices, volumes, arbitrage opportunities, and implications on company profits by BNP Paribas Exane
- INVEST SECURITIES – MRM : Un rendement toujours attractif - NEUTRE, OC 20,0€ vs 25,1€ by Invest Securities
- OFS 2024: More of the same, please by BNP Paribas Exane
- Pulling the brakes ahead of a bumpy FY25 by BNP Paribas Exane
- AI (+) and Non AI (-) by BNP Paribas Exane
- 888 by BNP Paribas Exane
- Weekly prescription tracker by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Year ahead 2024 by BNP Paribas Exane
- Frontline (Buy, TP: NOK257.00) - Case intact despite lower volumes by DnB Markets
- The weekly navigator by DnB Markets
- Valuation and market update by DnB Markets
- JM, deals and share issues by DnB Markets
- Nokia (Buy, TP: EUR4.00) - Our take on media speculation that AT&T may remove Nokia as RAN vendor by DnB Markets
- Strong growth, helped by low base by BNP Paribas Exane
- CMD preview: separation anxiety by BNP Paribas Exane
- Sustainability Weekly 27 November– 1 December 2023 by Oddo BHF
- Viaplay Group - Hold: Set to be a zombie for the foreseeable future by Nordea
- Ahead, Tougher Times by BNP Paribas Exane
- Value or Value Traps? (Sector Initiation) by BNP Paribas Exane
- Ahead of your dental check-up by BNP Paribas Exane
- Initiating at Underperform by BNP Paribas Exane